In the completed multiple ascending dose (MAD) portion of the Phase 1/2 open-label HALOS study, ION582 provided consistent and encouraging clinical improvement on all functional domains including ...

In your biological library, known as the brain, there are countless stories stored across billions of shelves. But with age, some sections start to collapse. No ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

This study presents a fast method for generating human microglia from iPSCs, paving the way for breakthroughs in ...

A new study in Neurodegenerative Diseases looks closely at how Parkinson’s disease can affect something as everyday and ...

Machine learning (ML) and artificial intelligence (AI) can help experts speed up the diagnosis and develop new treatments for Parkinson’s Disease. “By transforming our understanding of the brain and ...